Investor Relations

IR Home

Stock Chart
VNDA (Common)
ExchangeNASDAQ (US Dollar)
Price$15.95
Change (%) Stock is Up 0.05 (0.31%)
Volume332,423
Data as of 12/09/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Latest Presentation
Download Documentation Piper Jaffray Healthcare Conference Presentation
Download Documentation  Stifel 2016 Healthcare Conference Presentation
December 2016?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-4-3-2-1123
45678
12/08/16
8-K
Formats:  Excel HTML Adobe PDF Word
910
11121314151617
18192021222324
25262728293031

Primary IR Contact

For members of the press or investor community who wish to obtain more information about Vanda, please contact
Jim Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals, Inc.
(202) 734-3428

Recent News
12/07/16
Vanda Pharmaceuticals Settles Fanapt® Patent Litigation with Apotex
11/14/16
Vanda Pharmaceuticals Announces Participation at November 2016 Investor Conferences
11/02/16
Vanda Pharmaceuticals Reports Third Quarter 2016 Financial Results
More >>
Upcoming Events
There are currently no events scheduled.
More >>

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2007 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy